The presentation was supported by an unrestricted educational grant from Sanofi-Aventis U.S. Dr. Drake is a member of the speakers bureau for Sepracor; has received grants or research support from AstraZeneca within the last three years; serves as a consultant for Pfizer, Cephalon, and Sanofi-Aventis; and receives honoraria from Sepracor, Takeda, Pfizer and Cephalon.

Primary source: U.S. Psychiatric and Mental Health Congress regional extension

Pages: 1  2  3  4